SE437830B - Analogiforfarande for framstellning av 3-(1h-tetrazol-5-yl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat - Google Patents

Analogiforfarande for framstellning av 3-(1h-tetrazol-5-yl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat

Info

Publication number
SE437830B
SE437830B SE7805954A SE7805954A SE437830B SE 437830 B SE437830 B SE 437830B SE 7805954 A SE7805954 A SE 7805954A SE 7805954 A SE7805954 A SE 7805954A SE 437830 B SE437830 B SE 437830B
Authority
SE
Sweden
Prior art keywords
formula
mixture
pyrido
ethyl
azide
Prior art date
Application number
SE7805954A
Other languages
English (en)
Swedish (sv)
Other versions
SE7805954L (sv
Inventor
P F Juby
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7805954L publication Critical patent/SE7805954L/xx
Publication of SE437830B publication Critical patent/SE437830B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
SE7805954A 1977-05-25 1978-05-24 Analogiforfarande for framstellning av 3-(1h-tetrazol-5-yl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat SE437830B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/800,264 US4122274A (en) 1977-05-25 1977-05-25 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Publications (2)

Publication Number Publication Date
SE7805954L SE7805954L (sv) 1978-11-26
SE437830B true SE437830B (sv) 1985-03-18

Family

ID=25177928

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7805954A SE437830B (sv) 1977-05-25 1978-05-24 Analogiforfarande for framstellning av 3-(1h-tetrazol-5-yl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat

Country Status (26)

Country Link
US (1) US4122274A (nl)
JP (1) JPS6050197B2 (nl)
AT (1) AT365187B (nl)
AU (1) AU521211B2 (nl)
BE (1) BE867295A (nl)
CA (1) CA1098520A (nl)
CH (1) CH642656A5 (nl)
CY (1) CY1218A (nl)
DE (1) DE2822544A1 (nl)
DK (1) DK160279C (nl)
FI (1) FI64594C (nl)
FR (1) FR2401159A1 (nl)
GB (1) GB1596476A (nl)
GR (1) GR71887B (nl)
HK (1) HK25884A (nl)
IE (1) IE46849B1 (nl)
IT (1) IT1105040B (nl)
KE (1) KE3357A (nl)
LU (1) LU79694A1 (nl)
MY (1) MY8500305A (nl)
NL (1) NL190702C (nl)
NO (1) NO150361C (nl)
SE (1) SE437830B (nl)
SG (1) SG73383G (nl)
YU (2) YU42163B (nl)
ZA (1) ZA782816B (nl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
US4495189A (en) * 1975-11-27 1985-01-22 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Condensed pyrimidines
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
US4192944A (en) * 1978-04-03 1980-03-11 Bristol-Myers Company Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4282360A (en) * 1979-10-12 1981-08-04 Hoffmann-La Roche Inc. 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
US4507477A (en) * 1982-09-09 1985-03-26 Riker Laboratories, Inc. Process for tetrazolyl-pyrimidinone derivatives
US4474953A (en) * 1982-09-09 1984-10-02 Riker Laboratories, Inc. Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
AU588917B2 (en) * 1985-09-25 1989-09-28 Shionogi & Co., Ltd. 9-(substituted thio)-4h-pryido(1,2-a) pyrimidin-4-one derivatives
JPS63183581A (ja) * 1985-10-03 1988-07-28 Tokyo Tanabe Co Ltd ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬
JPS62242682A (ja) * 1986-04-16 1987-10-23 Tokyo Tanabe Co Ltd 新規なピリド［１，２―ａ］ピリミジン誘導体及びその製造法
JP2504788B2 (ja) * 1987-11-10 1996-06-05 東京田辺製薬株式会社 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤
KR920002329B1 (ko) * 1987-12-25 1992-03-21 산뗑 세이야꾸 가부시끼가이샤 항-알레르기성 점안제
CA2010336C (en) * 1989-02-27 1996-11-19 Atsunori Sano Process for producing pyrido[1,2-a]pyrimidine derivative
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
EP0653209A4 (en) 1992-07-30 1997-03-19 Tokyo Tanabe Co MEDICINAL PRODUCTS FOR INFLAMMATORY COLON DISEASES.
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
JPH0892093A (ja) * 1994-11-10 1996-04-09 Tokyo Tanabe Co Ltd ９−メチル−３−（１Ｈ−テトラゾール−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンの水性製剤
WO2002072580A1 (fr) * 2001-02-26 2002-09-19 Mitsubishi Pharma Corporation Preventifs et/ou remedes contres des maladies renales et l'insuffisance renale
ITMI20011764A1 (it) 2001-08-10 2003-02-10 Dinamite Dipharma Spa Metodo per l'ottenimento del pemirolast ad elevata purezza
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
NZ577467A (en) * 2006-12-18 2012-04-27 Cardoz Ab Combination of pemirolast and a statin for use in the treatment of inflammatory disorders
AU2007336077A1 (en) * 2006-12-20 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007679A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
US20100184783A1 (en) * 2007-07-11 2010-07-22 Johan Raud Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
ES2395002T3 (es) * 2008-04-07 2013-02-07 Cardoz Ab Nueva combinación para uso en el tratamiento de trastornos inflamatorios
UY32711A (es) 2009-06-16 2011-01-31 Cardoz Ab Nueva forma cristalina de pemirolast
USD661900S1 (en) 2010-02-22 2012-06-19 Bajer Design & Marketing, Inc. Collapsible structure
WO2013119916A2 (en) * 2012-02-10 2013-08-15 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
MX352962B (es) 2012-03-01 2017-12-15 Ptc Therapeutics Inc Compuestos para tratar atrofia muscular espinal.
EP2828247B1 (en) 2012-03-23 2019-01-16 PTC Therapeutics, Inc. 4h-chromen-4-one derivatives for treating spinal muscular atrophy
WO2015105657A1 (en) 2013-12-19 2015-07-16 Ptc Therapeutics, Inc. Methods for modulating the amount of rna transcripts
US20160243122A1 (en) 2014-10-23 2016-08-25 Rspr Pharma Ab Use of pemirolast in the treatment of acute asthma
WO2016102941A1 (en) 2014-12-22 2016-06-30 Rspr Pharma Ab New combination of pemirolast and montelukast
CN107635999B (zh) * 2015-05-20 2020-09-25 豪夫迈·罗氏有限公司 用于治疗脊髓性肌萎缩的化合物
EP4249472A3 (en) 2015-05-30 2023-12-13 PTC Therapeutics, Inc. Methods for modulating rna splicing
GB201518831D0 (en) 2015-10-23 2015-12-09 Rspr Pharma Ab New use
ES2879995T3 (es) 2015-12-10 2021-11-23 Ptc Therapeutics Inc Métodos para el tratamiento de la enfermedad de Huntington
GB201601138D0 (en) * 2016-01-21 2016-03-09 Rspr Pharma Ab New use
CN110352007A (zh) 2016-11-28 2019-10-18 Ptc医疗公司 用于调节rna剪接的方法
WO2018226622A1 (en) 2017-06-05 2018-12-13 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
BR112019026508A2 (pt) 2017-06-14 2020-07-14 Ptc Therapeutics, Inc. métodos para modificar o splicing do rna
CA3067592A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
EP3644996B1 (en) 2017-06-28 2023-07-26 PTC Therapeutics, Inc. Methods for treating huntington's disease
JP7399870B2 (ja) 2018-03-27 2023-12-18 ピーティーシー セラピューティクス， インコーポレイテッド ハンチントン病を処置するための化合物
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
WO2020005873A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating huntington's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072485A (en) * 1960-08-24 1963-01-08 Eastman Kodak Co Optically sensitized azido polymers for photomechanical resist compositions
AT286990B (de) * 1966-11-02 1971-01-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen
US3960847A (en) * 1972-04-17 1976-06-01 E. R. Squibb & Sons, Inc. 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
US4012387A (en) * 1975-09-18 1977-03-15 Warner-Lambert Company Benzo-[g]pyrido[2,1-b]quinazolinones

Also Published As

Publication number Publication date
BE867295A (fr) 1978-11-20
SE7805954L (sv) 1978-11-26
GB1596476A (en) 1981-08-26
SG73383G (en) 1984-08-03
GR71887B (nl) 1983-08-04
IE781036L (en) 1978-11-25
CH642656A5 (de) 1984-04-30
YU42163B (en) 1988-06-30
DK160279C (da) 1991-07-22
NL190702C (nl) 1994-07-01
YU233082A (en) 1988-08-31
IE46849B1 (en) 1983-10-05
FR2401159A1 (fr) 1979-03-23
NO150361B (no) 1984-06-25
AU521211B2 (en) 1982-03-25
YU123678A (en) 1983-02-28
US4122274A (en) 1978-10-24
FI64594C (fi) 1983-12-12
YU44212B (en) 1990-04-30
DE2822544A1 (de) 1978-12-07
MY8500305A (en) 1985-12-31
FI781614A (fi) 1978-11-26
LU79694A1 (fr) 1979-02-02
JPS6050197B2 (ja) 1985-11-07
HK25884A (en) 1984-03-30
JPS5436294A (en) 1979-03-16
CY1218A (en) 1984-04-06
NL190702B (nl) 1994-02-01
AU3631978A (en) 1979-11-29
IT7849523A0 (it) 1978-05-24
DK160279B (da) 1991-02-18
ZA782816B (en) 1979-05-30
FI64594B (fi) 1983-08-31
IT1105040B (it) 1985-10-28
FR2401159B1 (nl) 1983-05-20
DE2822544C2 (nl) 1988-10-27
DK228878A (da) 1978-11-26
NL7805534A (nl) 1978-11-28
NO781786L (no) 1978-11-28
NO150361C (no) 1984-10-03
CA1098520A (en) 1981-03-31
AT365187B (de) 1981-12-28
ATA373278A (de) 1981-05-15
KE3357A (en) 1984-02-03

Similar Documents

Publication Publication Date Title
SE437830B (sv) Analogiforfarande for framstellning av 3-(1h-tetrazol-5-yl)-4h-pyrido/1,2-a/pyrimidin-4-on-derivat
JP2955318B2 (ja) 置換ピリミジン誘導体
US20020065290A1 (en) Novel deazapurine derivatives: a new class of CRF1 specific ligands
IE47965B1 (en) Cycloalkyltriazoles and process for obtaining same
JPH0146514B2 (nl)
CA1119596A (en) Process for preparing new pyrrolo-quinoxalines and salts thereof
JPH0141637B2 (nl)
EP0244201B1 (en) 3-hydroxypyridines
JPS5995287A (ja) ２−（ピリジニルまたはヒドロキシフエニル）８−置換ピリド〔２，３−ｄ〕ピリミジン−５（８Ｈ）−オン類、その製造方法およびそれを含む医薬組成物
JP3334988B2 (ja) 新規の２−シアノ−３−ヒドロキシプロペンアミド、その製造方法、それを含有する製薬組成物及びその薬剤としての使用
US4192944A (en) Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4082751A (en) Therapeutic agents
SE438335B (sv) Pyrimido(2,1-a)isokinolin-derivat och farmaceutisk komposition
GB2154583A (en) pyrimidobenzthiazoles
US4496569A (en) Antiallergic (1H-tetrazol-5-yl)tetrazolo[1,5-a]quinolines and derivatives thereof
US6495686B2 (en) Pyrimido [4,5,b]indolizine derivatives and aza analogues thereof; CRF1 specific ligands
JP7148769B2 (ja) 複素環化合物又はその塩、ｇｐｒ３５作動薬及び医薬組成物
KR900001549B1 (ko) 3-(1H-테트라졸-5-일)티에노[2,3-d]피리미딘-4(3H)-온
EP0210648A1 (en) 5-chloro-s-triazolo/4,3-a/pyridine-7-carboxylic acids
DE2705609A1 (de) 2-phenyl-5-(5-1h-tetrazolyl)-pyrimidin-4(3h)-on-derivate, verfahren zu ihrer herstellung und arzneimittel
IE48611B1 (en) Imidazo(1,2-a)quinoxaline derivatives
JPS60226887A (ja) トリアゾロピリミジン誘導体
PL97987B1 (pl) Sposob wytwarzania nowych kwasow lub estrow/4,5-b/-pirymido-(3h)-chinolinonow-4
JPH07316162A (ja) 三環式化合物

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7805954-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7805954-0

Format of ref document f/p: F